Dr. Saklayen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4100 W 3rd St
Dayton, OH 45428Phone+1 937-268-6511Fax+1 937-267-7689
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Nephrology, 1980 - 1983
Icahn School of Medicine at Mount Sinai (Cabrini)Residency, Internal Medicine, 1977 - 1980
Dhaka Medical CollegeClass of 1974
Certifications & Licensure
OH State Medical License 1981 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Mucomyst for Hepatitis C Start of enrollment: 2006 Nov 01
- Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria Start of enrollment: 2006 Sep 01
- Spironolactone for Reducing Proteinuria in Diabetic Nephropathy Start of enrollment: 2003 Jan 01
Publications & Presentations
PubMed
- 1864 citationsThe Global Epidemic of the Metabolic Syndrome.Mohammad G. Saklayen
Current Hypertension Reports. 2018-02-26 - 116 citationsEffect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.Gemma Currie, Alison Taylor, Toshiro Fujita, Hiroshi Ohtsu, Morten Lindhardt
BMC Nephrology. 2016-09-08 - 44 citationsKinetics of oral tolerance: study of variables affecting tolerance induced by oral administration of antigen.Mohammad G. Saklayen, Amadeo J. Pesce, Victor E. Pollak, Gabriel Michael
International Archives of Allergy and Applied Immunology. 1984-07-01
Press Mentions
The Blood-Pressure LowdownAugust 26th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
